RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) Without Center Involved-Diabetic Macular Edema (CI-DME)

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) Without Center Involved-Diabetic Macular Edema (CI-DME)

Retinal Research Institute, LLC

Phoenix, Arizona, United States, 85014

Principal Investigator: Phoenix Site PI         

California Retina Consultants

Bakersfield, California, United States, 93309

Principal Investigator: Bakersfield Site PI         

Retina-Vitreous Associates Medical Group

Beverly Hills, California, United States, 90017

Principal Investigator: Beverly Hills Site PI         

Retinal Diagnostic Center

Campbell, California, United States, 95008

Principal Investigator: Campbell Site PI         

Northern California Retina Vitreous Associates Medical Group, Inc.

Mountain View, California, United States, 94040

Principal Investigator: Mountain View Site PI         

California Eye Specialists Medical Group, Inc

Pasadena, California, United States, 91107

Principal Investigator: Pasadena Site PI         

Retinal Consultants San Diego

Poway, California, United States, 92064

Principal Investigator: Poway Site PI         

California Retina Consultants

Santa Barbara, California, United States, 93103

Principal Investigator: Santa Barbara Site PI         

Southeast Retina Center, PC

Augusta, Georgia, United States, 30909

Principal Investigator: Augusta Site PI         

University Retina and Macula Associates, PC

Oak Forest, Illinois, United States, 60452

Principal Investigator: Oak Forest Site PI         

Wilmer Eye Institute/Johns Hopkins University School of Medicine

Baltimore, Maryland, United States, 21287

Principal Investigator: Baltimore Site PI         

Cumberland Valley Retina Consultants

Hagerstown, Maryland, United States, 21740

Principal Investigator: Hagerstown Site PI         

Ophthalmic Consultants of Boston

Boston, Massachusetts, United States, 02114

Principal Investigator: Boston Site PI         

Sierra Eye Associates

Reno, Nevada, United States, 89502

Principal Investigator: Reno Site PI         

NJ Retina

Teaneck, New Jersey, United States, 07666

Principal Investigator: Teaneck Site PI         

Vision Research Center Eye Associates of New Mexico

Albuquerque, New Mexico, United States, 87109

Principal Investigator: Albuquerque Site PI         

Duke University Eye Center

Durham, North Carolina, United States, 27705

Principal Investigator: Durham Site PI         

Mid Atlantic Retina

Philadelphia, Pennsylvania, United States, 19107

Principal Investigator: Philadelphia Site PI         

Charles Retina Institute, P.C.

Germantown, Tennessee, United States, 38138

Principal Investigator: Germantown Site PI         

Austin Clinical Research, LLC

Austin, Texas, United States, 78750

Principal Investigator: Austin Site PI         

Retinal Consultants of Texas

The Woodlands, Texas, United States, 77384

Principal Investigator: Woodlands Site PI         

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 18, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine